PAUL THOMAS - 01 Sep 2023 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Paul Thomas
Issuer symbol
AXGN
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
4
Filing time
07 Sep 2023, 06:30:54 UTC
Previous filing
05 Jun 2023
Next filing
10 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to purchase) Award $0 +20,436 $0.000000 20,436 01 Sep 2023 Common Stock 20,436 $6.30 Direct F1
transaction AXGN Restricted Stock Units Award $0 +11,904 $0.000000 11,904 01 Sep 2023 Common Stock 11,904 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.